Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.
The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.
Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...
Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback